Management transactions

Each manager must notify Optomed and the FIN-FSA of every transaction in the financial instruments of the company conducted on his/her own account.¹

Last modified: 5.9.2024

The notifications shall be made promptly and no later than three business days after the date of the transaction (T+3).

In light of Optomed’s obligation to publish such information, managers must submit an informal notice to Optomed (sakari.knuutti@optomed.com and susanna.latvala-andersson@optomed.com) on the date of the transaction and that the actual notification is made to Optomed at the latest within two business days after the date of the transaction (T+2).

The notification shall be sent in electronic format to Optomed’s insider administration (sakari.knuutti@optomed.com and susanna.latvala-andersson@optomed.com) and to the FIN-FSA (by sending a secure email at the web page https://securemail.bof.fi to the address johdonkaupat@finanssivalvonta.fi) by using the form approved by the FIN-FSA, which is available at the FIN-FSA’s website (Related Document G) and include the information specified therein. The company’s insider administration may be contacted for further information.

If a manager authorises another person (e.g. an asset manager) to make the notifications on its behalf, information thereof (and the contact details of the relevant authorised persons) shall be submitted to the insider administration in writing. Such authorisation does not relieve the relevant manager from his/her liability.

1 Under MAR, a person’s obligation to notify transactions applies in respect of the relevant person, once a total amount of EUR 5,000 has been reached within a calendar year (the threshold is calculated by adding without netting all transactions conducted within a certain calendar year).However, Optomed recommends that all transactions are notified (also below the threshold). Optomed also intends to publish all transactions notified to Optomed (whether or not the 5,000 euro limit has been reached).

 

Management holdings:

Optomed discloses manager’s transactions as stock exchange releases no later than three business days after the date of the transaction (T+3). The contents of this site are updated at least quarterly.

Board and Management shareholding 1.9.2024:

  Name

Position

 

Own and
controlled shares

Options

 

Petri Salonen

Chairman of the Board of Directors

16 179

Catherine Calarco

Member of the Board of Directors

3 405

Seppo Mäkinen

Member of the Board of Directors

12 192

Reijo Tauriainen

Member of the Board of Directors

15 271

Anna Tenstam

Member of the Board of Directors

7 192

Ty Lee

Member of the Board of Directors

3 405

  Total

57 644

 

  Name

Position

 

Own and
controlled shares

Options

 

  Juho Himberg

CEO

30 000

200 0004

  Sakari Knuutti

Chief Financial Officer

127 8751

  Markku Myllylä

Vice President, Software

76 3752

  Laura Piila

Vice President, Devices

30 000

118 8753

  Total

60 000

523,125

1) of which 2024A: 50 000, 2022A: 57 875, 2019C: 20 000
2) of which 2024A: 2500, 2022A: 13 875, 2019A: 60 000
3) of which 2017B 20 000, 2022A 35 000, 2024A 63 875
4) of which 2024A: 150 000, 2022A: 50 000